Mast Cell Stabilizing Properties of Antihistamines
- 1 November 2009
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (11) , 2549-2551
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Desloratadine Inhibits Human Skin Mast Cell Activation and Histamine ReleaseJournal of Investigative Dermatology, 2009
- The role of histamine H4receptor in immune and inflammatory disordersBritish Journal of Pharmacology, 2009
- New oral H1 antihistamines in children: facts and unmeet needsAllergy, 2008
- Inhibition of allergen‐induced wheal and flare reactions by levocetirizine and desloratadineBritish Journal of Clinical Pharmacology, 2007
- Anti‐inflammatory properties of desloratadineClinical & Experimental Allergy, 2004
- Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastineAnnals of Allergy, Asthma & Immunology, 2000
- Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI+cellsClinical & Experimental Allergy, 1997
- In vitro effects of H1‐antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skinAllergy, 1994
- Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influxJournal of Allergy and Clinical Immunology, 1990
- Calmodulin in mast cells and its role in histamine secretionInflammation Research, 1985